
XRHealth Buys Swing to Consolidate Digital Therapeutics
The acquisition of Swing Therapeutics by XRHealth reveals a harsh truth: in digital health, standalone apps cannot survive alone.
Discover the newest research about AI innovations in 🧠Digital Therapeutics.

The acquisition of Swing Therapeutics by XRHealth reveals a harsh truth: in digital health, standalone apps cannot survive alone.

A newly launched video game prescription signals a massive shift in how conservative medical systems handle pediatric mental health.

Silicon Valley wants to monitor the one vital health metric your smartwatch cannot reach.

By analyzing the grammar of sleep stages rather than raw brainwaves, a new AI bypasses the need for expensive clinical hardware.

The FDA just cleared its first patient-facing generative AI tool, but the algorithm is not the one writing your prescription.

The regulatory approval of a non-invasive brain stimulation headset for PTSD exposes a massive, decades-long stagnation in psychiatric drug development.

A national health system is handing its musculoskeletal care over to algorithms, setting up a massive test case for automated medicine.

A delayed regulatory nod puts Boston Scientific’s multi-billion-dollar bet to the test.

Algorithms can now recommend insulin doses as safely as human specialists, shifting the bottleneck of diabetes care from clinical expertise to patient trust.

A massive new funding round proves that health systems are ready to delegate daily clinical tasks to supervised AI agents.